2 October 2026
Learn about Vitality's GLP-1 obesity support and how it supports successful weight loss through assessments and personalised programs.
25 August 2026
GLP-1 generics could cut obesity drug costs, challenge illegal sales and expand access as more semaglutide products seek approval.
17 June 2026
Diabetes Deaths In South Africa reached 27,692 in 2023, raising calls for screening, education and urgent public health action.
19 May 2026
GLP-1 Drugs In SA could spread as cheaper generics and oral pills arrive, changing food and alcohol demand and pushing premium health trends.
29 March 2026
Learn how acknowledging obesity as a chronic disease can transform healthcare approaches and reduce long-term health costs.
23 March 2026
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
19 January 2026
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
14 January 2026
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
8 January 2026
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
11 November 2025
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
15 October 2025
Aspen shares soar following the approval of Mounjaro for weight loss in South Africa. Discover the impact on obesity management.
11 September 2025